The genome-wide expression profile of 1,2,3,4,6-penta-O-galloyl-ß-D- glucose-treated MDA-MB-231 breast cancer cells: Molecular target on cancer metabolism

Molecules and Cells

Volumn 32, Issue 2, 2011, Pages 123-132

  Yu, Woo Sik ^a   Jeong, Soo Jin ^a   Kim, Ji Hyun ^a   Lee, Hyo Jung ^a   Song, Hyo Sook ^a   Kim, Min Seok ^b   Ko, Eunjung ^a   Lee, Hyo Jeong ^a   Khil, Jae Ho ^a   Jang, Hyeung Jin ^a   Kim, Young Chul ^a   Bae, Hyunsu ^a   Chen, Chang Yan ^c   Kim, Sung Hoon ^a  

^a Kyung Hee University   (South Korea)

^b TUFTS UNIVERSITY SCHOOL OF DENTAL MEDICINE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cancer metabolism; MDA MB 231; Microarray; PGG; Real time PCR

Indexed keywords

1,2,3,4,6 PENTA O GALLOYL BETA DEXTRO GLUCOSE; CATECHOL METHYLTRANSFERASE; MESSENGER RNA; POLYPHENOL; PYRUVIC ACID; TYROSINE; UNCLASSIFIED DRUG;

AMINO ACID METABOLISM; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CELL METABOLISM; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENE TARGETING; GLUCONEOGENESIS; GLYCOLYSIS; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; POISON IVY; REAL TIME POLYMERASE CHAIN REACTION; RHUS CHINENSIS; TUMOR GENE;

ANGIOGENESIS INHIBITORS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL LINE, TUMOR; DRUGS, CHINESE HERBAL; FEMALE; GENOME-WIDE ASSOCIATION STUDY; GLYCOLYSIS; HUMANS; HYDROLYZABLE TANNINS; MICROARRAY ANALYSIS; MOLECULAR TARGETED THERAPY; PYRUVIC ACID; RHUS; TYROSINE;

RHUS CHINENSIS;

EID: 81055157964     PISSN: 10168478     EISSN: 02191032     Source Type: Journal    
DOI: 10.1007/s10059-011-2254-1     Document Type: Article

References (69)

1. Beckers, A., Organe, S., Timmermans, L., Scheys, K., Peeters, A., Brusselmans, K., Verhoeven, G., and Swinnen, J.V. (2007). Chemical inhibition of acetyl-CoA carboxylase induces growth arrest and cytotoxicity selectively in cancer cells. Cancer Res. 67, 8180-8187. (Pubitemid 47395154)
2. Brownsey, R.W., Zhande, R., and Boone, A.N. (1997). Isoforms of acetyl-CoA carboxylase: structures, regulatory properties and metabolic functions. Biochem. Soc. Trans. 25, 1232-1238. (Pubitemid 27528569)
3. Butte, A.J., Dzau, V.J., and Glueck, S.B. (2001). Further defining housekeeping, or "maintenance," genes focus on "A compendium of gene expression in normal human tissues". Physiol. Genomics 7, 95-96.
4. Calamai, M., Canale, C., Relini, A., Stefani, M., Chiti, F., and Dobson, C.M. (2005). Reversal of protein aggregation provides evidence for multiple aggregated States. J. Mol. Biol. 346, 603-616.
5. Cavalher-Machado, S.C., Rosas, E.C., Brito Fde, A., Heringe, A.P., de Oliveira, R.R., Kaplan, M.A., Figueiredo, M.R., and Henriques, M.G. (2008). The anti-allergic activity of the acetate fraction of Schinus terebinthifolius leaves in IgE induced mice paw edema and pleurisy. Int. Immunopharmacol. 8, 1552-1560.
6. Cecchi, C., Liguri, G., Fiorillo, C., Bogani, F., Gambassi, M., Giannoni, E., Cirri, P., Baglioni, S., and Ramponi, G. (2004). Acylphosphatase overexpression triggers SH-SY5Y differentiation towards neuronal phenotype. Cell. Mol. Life Sci. 61, 1775-1784. (Pubitemid 39044255)
7. Chen, W.J., and Lin, J.K. (2004). Induction of G1 arrest and apoptosis in human jurkat T cells by pentagalloylglucose through inhibiting proteasome activity and elevating p27Kip1, p21Cip1/ WAF1, and Bax proteins. J. Biol. Chem. 279, 13496-13505.
8. Cheung, N., Chan, L.C., Thompson, A., Cleary, M.L., and So, C.W. (2007). Protein arginine-methyltransferase-dependent oncogenesis. Nat. Cell Biol. 9, 1208-1215. (Pubitemid 47500498)
9. Crabb, D.W., Matsumoto, M., Chang, D., and You, M. (2004). Overview of the role of alcohol dehydrogenase and aldehyde dehydrogenase and their variants in the genesis of alcohol-related pathology. Proc. Nutr. Soc. 63, 49-63. (Pubitemid 38543873)
10. Evans, M.J., Saghatelian, A., Sorensen, E.J., and Cravatt, B.F. (2005). Target discovery in small-molecule cell-based screens by in situ proteome reactivity profiling. Nat. Biotechnol. 23, 1303-1307. (Pubitemid 41486859)
11. Feron, O. (2009). Pyruvate into lactate and back: from the Warburg effect to symbiotic energy fuel exchange in cancer cells. Radiother. Oncol. 92, 329-333.
12. Geschwind, J.F., Ko, Y.H., Torbenson, M.S., Magee, C., and Pedersen, P.L. (2002). Novel therapy for liver cancer: direct intraarterial injection of a potent inhibitor of ATP production. Cancer Res. 62, 3909-3913. (Pubitemid 34791050)
13. Geschwind, J.F., Georgiades, C.S., Ko, Y.H., and Pedersen, P.L. (2004). Recently elucidated energy catabolism pathways provide opportunities for novel treatments in hepatocellular carcinoma. Expert Rev. Anticancer Ther. 4, 449-457. (Pubitemid 38745116)
14. Harwood, H.J., Jr., Petras, S.F., Shelly, L.D., Zaccaro, L.M., Perry, D.A., Makowski, M.R., Hargrove, D.M., Martin, K.A., Tracey, W.R., Chapman, J.G., et al. (2003). Isozyme-nonselective N-substituted bipiperidylcarboxamide acetyl-CoA carboxylase inhibitors reduce tissue malonyl-CoA concentrations, inhibit fatty acid synthesis, and increase fatty acid oxidation in cultured cells and in experimental animals. J. Biol. Chem. 278, 37099-37111. (Pubitemid 37175224)
15. Hilton, J. (1984). Role of aldehyde dehydrogenase in cyclophosphamide- resistant L1210 leukemia. Cancer Res. 44, 5156-5160. (Pubitemid 15204481)
16. Ho, L.L., Chen, W.J., Lin-Shiau, S.Y., and Lin, J.K. (2002). Penta-Ogalloyl- beta-D-glucose inhibits the invasion of mouse melanoma by suppressing metalloproteinase-9 through down-regulation of activator protein-1. Eur. J. Pharmacol. 453, 149-158.
17. Hofmann, A.S., and Gross, G.G. (1990). Biosynthesis of gallotannins: formation of polygalloylglucoses by enzymatic acylation of 1,2,3,4,6-penta-O- galloylglucose. Arch. Biochem. Biophys. 283, 530-532.
18. Hu, H., Lee, H.J., Jiang, C., Zhang, J., Wang, L., Zhao, Y., Xiang, Q., Lee, E.O., Kim, S.H., and Lu, J. (2008). Penta-1,2,3,4,6-Ogalloyl- beta-D-glucose induces p53 and inhibits STAT3 in prostate cancer cells in vitro and suppresses prostate xenograft tumor growth in vivo. Mol. Cancer Ther. 7, 2681-2691.
19. Hu, H., Chai, Y., Wang, L., Zhang, J., Lee, H.J., Kim, S.H., and Lu, J. (2009a). Pentagalloylglucose induces autophagy and caspaseindependent programmed deaths in human PC-3 and mouse TRAMP-C2 prostate cancer cells. Mol. Cancer Ther. 8, 2833-2843.
20. Hu, H., Zhang, J., Lee, H.J., Kim, S.H., and Lu, J. (2009b). Penta- O-galloyl-beta-D-glucose induces S- and G(1)-cell cycle arrests in prostate cancer cells targeting DNA replication and cyclin D1. Carcinogenesis 30, 818-823.
21. Hua, K.T., Way, T.D., and Lin, J.K. (2006). Pentagalloylglucose inhibits estrogen receptor alpha by lysosome-dependent depletion and modulates ErbB/PI3K/Akt pathway in human breast cancer MCF-7 cells. Mol. Carcinog. 45, 551-560.
22. Huh, J.E., Lee, E.O., Kim, M.S., Kang, K.S., Kim, C.H., Cha, B.C., Surh, Y.J., and Kim, S.H. (2005). Penta-O-galloyl-beta-D-glucose suppresses tumor growth via inhibition of angiogenesis and stimulation of apoptosis: roles of cyclooxygenase-2 and mitogen- activated protein kinase pathways. Carcinogenesis 26, 1436-1445.
23. Ji, M.S., Piao, X.L., Jin, Y.L., and Park, R.D. (2005). Anticoagulant 1,2,3,4,6-pentagalloyl-beta-D-glucopyranose isolated from geranium (Pelargonium inquinans Ait). Arch. Pharm. Res. 28, 1037-1041. (Pubitemid 41426849)
24. Jump, D.B., Torres-Gonzalez, M., and Olson, L.K. (2010). Soraphen A, an inhibitor of acetyl CoA carboxylase activity, interferes with fatty acid elongation. Biochem. Pharmacol. 81, 649-660.
25. Kobrinsky, N.L., and Sjolander, D.E. (2006). Response of metastatic recurrent neuroblastoma to nitisinone: a modulator of tyrosine metabolism. Pediatr. Blood Cancer 46, 517-520. (Pubitemid 43334663)
26. Kuo, P.T., Lin, T.P., Liu, L.C., Huang, C.H., Lin, J.K., Kao, J.Y., and Way, T.D. (2009). Penta-O-galloyl-beta-D-glucose suppresses prostate cancer bone metastasis by transcriptionally repressing EGF-induced MMP-9 expression. J. Agric. Food Chem. 57, 3331-3339.
27. Lee, S.J., Lee, H.M., Ji, S.T., Lee, S.R., Mar, W., and Gho, Y.S. (2004). 1,2,3,4,6-Penta-O-galloyl-beta-D-glucose blocks endothelial cell growth and tube formation through inhibition of VEGF binding to VEGF receptor. Cancer Lett. 208, 89-94. (Pubitemid 38501788)
28. Lee, S.J., Lee, H.K., Jung, M.K., and Mar, W. (2006). In vitro antiviral activity of 1,2,3,4,6-penta-O-galloyl-beta-D-glucose against he-patitis B virus. Biol. Pharm. Bull. 29, 2131-2134. (Pubitemid 44510823)
29. Lee, J.H., Yehl, M., Ahn, K.S., Kim, S.H., and Lieske, J.C. (2009a). 1,2,3,4,6-penta-O-galloyl-beta-D-glucose attenuates renal cell migration, hyaluronan expression, and crystal adhesion. Eur. J. Pharmacol. 606, 32-37.
30. Lee, T.X., Packer, M.D., Huang, J., Akhmametyeva, E.M., Kulp, S.K., Chen, C.S., Giovannini, M., Jacob, A., Welling, D.B., and Chang, L.S. (2009b). Growth inhibitory and anti-tumour activities of OSU-03012, a novel PDK-1 inhibitor, on vestibular schwannoma and malignant schwannoma cells. Eur. J. Cancer 45, 1709-1720.
31. Lee, C.H., Jeong, S.J., Yun, S.M., Kim, J.H., Lee, H.J., Ahn, K.S., Won, S.H., Kim, H.S., Zhu, S., Chen, C.Y., et al. (2011a). Downregulation of phosphoglucomutase 3 mediates sulforaphaneinduced cell death in LNCaP prostate cancer cells. Proteome Sci. 8, 67.
32. Lee, H.J., Seo, N.J., Jeong, S.J., Park, Y., Jung, D.B., Koh, W., Lee, E.O., Ahn, K.S., Lu, J., and Kim, S.H. (2011b). Oral administration of Penta-O-galloyl-{beta}-D-glucose suppresses triple-negative breast cancer xenograft growth and metastasis in strong association with JAK1-STAT3 Inhibition. Carcinogenesis [Epub ahead of print].
33. Li, Y., Kim, J., Li, J., Liu, F., Liu, X., Himmeldirk, K., Ren, Y., Wagner, T.E., and Chen, X. (2005). Natural anti-diabetic compound 1,2,3,4,6-penta-O-galloyl-D-glucopyranose binds to insulin receptor and activates insulin-mediated glucose transport signaling pathway. Biochem. Biophys. Res. Commun. 336, 430-437. (Pubitemid 41267248)
34. Liu, X., Wang, X., Zhang, J., Lam, E.K., Shin, V.Y., Cheng, A.S., Yu, J., Chan, F.K., Sung, J.J., and Jin, H.C. (2010). Warburg effect revisited: an epigenetic link between glycolysis and gastric carcinogenesis. Oncogene 29, 442-450.
35. Madhusoodhanan, R., Natarajan, M., Singh, J.V., Jamgade, A., Awasthi, V., Anant, S., Herman, T.S., and Aravindan, N. (2010). Effect of black raspberry extract in inhibiting NFkappa B dependent radioprotection in human breast cancer cells. Nutr. Cancer 62, 93-104.
36. Maher, J.C., Krishan, A., and Lampidis, T.J. (2004). Greater cell cycle inhibition and cytotoxicity induced by 2-deoxy-D-glucose in tumor cells treated under hypoxic vs aerobic conditions. Cancer Chemother. Pharmacol. 53, 116-122. (Pubitemid 38186989)
37. Millikan, R.C., Pittman, G.S., Tse, C.K., Duell, E., Newman, B., Savitz, D., Moorman, P.G., Boissy, R.J., and Bell, D.A. (1998). Catechol-O- methyltransferase and breast cancer risk. Carcinogenesis 19, 1943-1947. (Pubitemid 28521935)
38. Moreb, J.S., Gabr, A., Vartikar, G.R., Gowda, S., Zucali, J.R., and Mohuczy, D. (2005). Retinoic acid down-regulates aldehyde dehydrogenase and increases cytotoxicity of 4-hydroperoxycyclophosphamide and acetaldehyde. J. Pharmacol. Exp. Ther. 312, 339-345. (Pubitemid 40096487)
39. Oh, G.S., Pae, H.O., Oh, H., Hong, S.G., Kim, I.K., Chai, K.Y., Yun, Y.G., Kwon, T.O., and Chung, H.T. (2001). In vitro anti-proliferative effect of 1,2,3,4,6-penta-O-galloyl-beta-D-glucose on human hepatocellular carcinoma cell line, SK-HEP-1 cells. Cancer Lett. 174, 17-24. (Pubitemid 33001304)
40. Oh, G.S., Pae, H.O., Choi, B.M., Lee, H.S., Kim, I.K., Yun, Y.G., Kim, J.D., and Chung, H.T. (2004). Penta-O-galloyl-beta-D-glucose inhibits phorbol myristate acetate-induced interleukin-8 [correction of intereukin-8] gene expression in human monocytic U937 cells through its inactivation of nuclear factor-kappaB. Int. Immunopharmacol. 4, 377-386. (Pubitemid 38375971)
41. Okuda, T., Mori, K., and Hayatsu, H. (1984). Inhibitory effect of tannins on direct-acting mutagens. Chem. Pharm. Bull. (Tokyo) 32, 3755-3758. (Pubitemid 14015779)
42. Onay, U.V., Aaltonen, K., Briollais, L., Knight, J.A., Pabalan, N., Kilpivaara, O., Andrulis, I.L., Blomqvist, C., Nevanlinna, H., and Ozcelik, H. (2008). Combined effect of CCND1 and COMT polymorphisms and increased breast cancer risk. BMC Cancer 8, 6.
43. Pae, H.O., Oh, G.S., Jeong, S.O., Jeong, G.S., Lee, B.S., Choi, B.M., Lee, H.S., and Chung, H.T. (2006). 1,2,3,4,6-penta-Ogalloyl- beta-D-glucose up-regulates heme oxygenase-1 expression by stimulating Nrf2 nuclear translocation in an extracellular signal-regulated kinase-dependent manner in HepG2 cells. World J. Gastroenterol. 12, 214-221.
44. Pan, M.H., Lin, J.H., Lin-Shiau, S.Y., and Lin, J.K. (1999). Induction of apoptosis by penta-O-galloyl-beta-D-glucose through activation of caspase-3 in human leukemia HL-60 cells. Eur. J. Pharmacol. 381, 171-183.
45. Pan, M.H., Lin-Shiau, S.Y., Ho, C.T., Lin, J.H., and Lin, J.K. (2000). Suppression of lipopolysaccharide-induced nuclear factorkappaB activity by theaflavin-3,3?-digallate from black tea and other polyphenols through down-regulation of IkappaB kinase activity in macrophages. Biochem. Pharmacol. 59, 357-367.
46. Pathania, D., Millard, M., and Neamati, N. (2009). Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism. Adv. Drug Deliv. Rev. 61, 1250-1275.
47. Pelicano, H., Carney, D., and Huang, P. (2004). ROS stress in cancer cells and therapeutic implications. Drug Resist. Updat. 7, 97-110. (Pubitemid 38736063)
48. Qi, C., Chang, J., Zhu, Y., Yeldandi, A.V., Rao, S.M., and Zhu, Y.J. (2002). Identification of protein arginine methyltransferase 2 as a coactivator for estrogen receptor alpha. J. Biol. Chem. 277, 28624-28630. (Pubitemid 41079291)
49. Rao, V.V., Anthony, D.C., and Piwnica-Worms, D. (1994). MDR1 gene-specific monoclonal antibody C494 cross-reacts with pyruvate carboxylase. Cancer Res. 54, 1536-1541. (Pubitemid 24106418)
50. Ray, R.B., Raychoudhuri, A., Steele, R., and Nerurkar, P. (2010). Bitter melon (Momordica charantia) extract inhibits breast cancer cell proliferation by modulating cell cycle regulatory genes and promotes apoptosis. Cancer Res. 70, 1925-1931.
51. Reddish, J.M., Ye, W., Lin, Y.C., and Wick, M. (2010). (-)-Gossypol containing hen sera and a myosin (-)-gossypol conjugate reduces the proliferation of MCF-7 cells. Anti Cancer Res. 30, 439-444.
52. Riedl, K.M., and Hagerman, A.E. (2001). Tannin-protein complexes as radical scavengers and radical sinks. J. Agric. Food Chem. 49, 4917-4923. (Pubitemid 32988740)
53. Riley, H.D., Macnab, J., Farrell, T.J., and Cohn, K. (1997). The expression of acylphosphatase is associated with the metastatic phenotype in human colorectal tumors. Carcinogenesis 18, 2453-2455. (Pubitemid 28134663)
54. Roche, T.E., and Hiromasa, Y. (2007). Pyruvate dehydrogenase kinase regulatory mechanisms and inhibition in treating diabetes, heart ischemia, and cancer. Cell. Mol. Life Sci. 64, 830-849. (Pubitemid 46597752)
55. Scatena, R., Bottoni, P., Pontoglio, A., Mastrototaro, L., and Giardina, B. (2008). Glycolytic enzyme inhibitors in cancer treatment. Expert Opin. Investig. Drugs 17, 1533-1545.
56. Schwer, B., Bunkenborg, J., Verdin, R.O., Andersen, J.S., and Verdin, E. (2006). Reversible lysine acetylation controls the activity of the mitochondrial enzyme acetyl-CoA synthetase 2. Proc. Natl. Acad. Sci. USA 103, 10224-10229. (Pubitemid 44051148)
57. Tong, L. (2005). Acetyl-coenzyme A carboxylase: crucial metabolic enzyme and attractive target for drug discovery. Cell. Mol. Life Sci. 62, 1784-1803. (Pubitemid 41188519)
58. Ulmanen, I., Peranen, J., Tenhunen, J., Tilgmann, C., Karhunen, T., Panula, P., Bernasconi, L., Aubry, J.P., and Lundstrom, K. (1997). Expression and intracellular localization of catechol Omethyltransferase in transfected mammalian cells. Eur. J. Biochem. 243, 452-459. (Pubitemid 27060435)
59. Warburg, O. (1956). On the origin of cancer cells. Science 123, 309-314.
60. Warburg, O., Wind, F., and Negelein, E. (1927). The metabolism of tumors in the body. J. Gen. Physiol. 8, 519-530.
61. Weisberg, E., Banerji, L., Wright, R.D., Barrett, R., Ray, A., Moreno, D., Catley, L., Jiang, J., Hall-Meyers, E., Sauveur-Michel, M., et al. (2008). Potentiation of antileukemic therapies by the dual PI3K/PDK-1 inhibitor, BAG956: effects on BCR-ABL- and mutant FLT3-expressing cells. Blood 111, 3723-3734.
62. Wen, W., Ren, Z., Shu, X.O., Cai, Q., Ye, C., Gao, Y.T., and Zheng, W. (2007). Expression of cytochrome P450 1B1 and catechol-Omethyltransferase in breast tissue and their associations with breast cancer risk. Cancer Epidemiol. Biomarkers Prev. 16, 917-920. (Pubitemid 46910092)
63. Xi, B., Zeng, T., and Liu, W. (2010). Catechol-O-methyltransferase Val158Met polymorphism in breast cancer risk. Breast Cancer Res. Treat. 126, 839-841.
64. Xu, R.H., Pelicano, H., Zhou, Y., Carew, J.S., Feng, L., Bhalla, K.N., Keating, M.J., and Huang, P. (2005). Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia. Cancer Res. 65, 613-621.
65. Yoshii, Y., Waki, A., Furukawa, T., Kiyono, Y., Mori, T., Yoshii, H., Kudo, T., Okazawa, H., Welch, M.J., and Fujibayashi, Y. (2009). Tumor uptake of radiolabeled acetate reflects the expression of cytosolic acetyl-CoA synthetase: implications for the mechanism of acetate PET. Nucl. Med. Biol. 36, 771-777.
66. Yu, J.S., and Kim, A.K. (2011). Wogonin induces apoptosis by activation of ERK and p38 MAPKs signaling pathways and generation of reactive oxygen species in human breast cancer cells. Mol. Cells 31, 327-335.
67. Yun, M., Bang, S.H., Kim, J.W., Park, J.Y., Kim, K.S., and Lee, J.D. (2009). The importance of acetyl coenzyme A synthetase for 11C-acetate uptake and cell survival in hepatocellular carcinoma. J. Nucl. Med. 50, 1222-1228.
68. Zhang, F., Luo, S.Y., Ye, Y.B., Zhao, W.H., Sun, X.G., Wang, Z.Q., Li, R., Sun, Y.H., Tian, W.X., and Zhang, Y.X. (2008). The antibacterial efficacy of an aceraceous plant [Shantung maple (Acer truncatum Bunge)] may be related to inhibition of bacterial betaoxoacyl- acyl carrier protein reductase (FabG). Biotechnol. Appl. Biochem. 51, 73-78.
69. Zhang, J., Li, L., Kim, S.H., Hagerman, A.E., and Lu, J. (2009). Anticancer, anti-diabetic and other pharmacologic and biological activities of penta-galloyl-glucose. Pharm. Res. 26, 2066-2080.